Follow The Filings

MSCI

MSCI earnings company data as of 4:47 AM ET 9/7

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 27 Oct EPS 5.01 — —
Rev — — —

Insider trades

Open-market buys and sales by MSCI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MSCI insider trades
  • $15.5M bought by 3 insiders
  • $6.3M sold by 2 insiders outside a trading plan
  • $1M sold by 1 insider under 10b5-1 plans
  1. Andrew C. Wiechmann CFO
    Planned sale
    $257K 450 shares at $570.00 2% of stake
    Traded Oct 12 Filed Oct 14
  2. Rajat Taneja Director
    Buy
    $1M 1,786 shares at $560.00 +49% to stake
    Traded Sep 2 Filed Sep 4
  3. Andrew C. Wiechmann CFO
    Planned sale
    $272K 450 shares at $604.56 2% of stake
    Traded Jun 10 Filed Jun 12
  4. Henry A Fernandez CEO
    Buy
    $2.2M 4,000 shares at $562.40 +0.2% to stake
    Traded May 15 Filed May 18
  5. Alvise J. Munari Chief Product Officer
    Sale
    $5.9M 10,000 shares at $592.04 30% of stake
    Traded Apr 24 Filed Apr 28
  6. Andrew C. Wiechmann CFO
    Planned sale
    $252K 450 shares at $560.00 2% of stake
    Traded Mar 17 Filed Mar 19
  7. Robert G. Ashe Director
    Buy
    $2M 3,681 shares at $543.21 +20% to stake
    Traded Feb 18 Filed Feb 20
  8. Henry A Fernandez CEO
    Buy
    $3.6M 6,800 shares at $523.56 +0.5% to stake
    Traded Feb 13–17 Filed Feb 17
  9. Andrew C. Wiechmann CFO
    Planned sale
    $248K 450 shares at $550.00 2% of stake
    Traded Dec 11, 2025 Filed Dec 12, 2025
  10. Henry A Fernandez CEO
    Buy
    $6.7M 12,500 shares at $536.14
    Traded Dec 5, 2025 Filed Dec 9, 2025
  11. Robert J. Gutowski General Counsel
    Sale
    $348K 624 shares at $558.42 3.8% of stake
    Traded Nov 24, 2025 Filed Nov 26, 2025

Also filed in the last 12 months, not counted as buying or selling: 30 stock grants, 5 share withholdings for taxes, and 4 gifts.

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
10-Q
8-K 2.02,9.01
8-K 5.02
8-K 2.02,9.01
10-Q
SCHEDULE 13G —
SCHEDULE 13G —
8-K 5.07
8-K 2.02,9.01
10-Q
8-K 5.02
SCHEDULE 13G/A —
DEF 14A
DEFA14A

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.